HIF1A and neoplasm: Inhibition of angiogenesis by metformin has been linked to suppression of HIF-1α via AMPK signaling (95, 96), or to inhibition of platelet-derived growth factor β (PDGF-β) that lead to normalization of tumor vasculature (97).